FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970782264> ?p ?o ?g. }

• W1970782264 endingPage "24784" @default.
• W1970782264 startingPage "24776" @default.
• W1970782264 abstract "Pancreatic cancer remains a devastating malignancy with a poor prognosis and is largely resistant to current therapies. To understand the resistance of pancreatic tumors to Fas death receptor-induced apoptosis, we investigated the molecular mechanisms of Fas-activated survival signaling in pancreatic cancer cells. We found that knockdown of the Fas-associated protein with death domain (FADD), the adaptor that mediates downstream signaling upon Fas activation, rendered Fas-sensitive MiaPaCa-2 and BxPC-3 pancreatic cells resistant to Fas-induced apoptosis. By contrast, Fas activation promoted the survival of the FADD knockdown MiaPaCa-2 and BxPC-3 cells in a concentration-dependent manner. The pharmacological inhibitor of ERK, PD98059, abrogated Fas-promoted cell survival in FADD knockdown MiaPaCa-2 and BxPC-3 cells. Furthermore, increased phosphorylation of Src was demonstrated to mediate Fas-induced ERK activation and cell survival. Immunoprecipitation of Fas in the FADD knockdown cells identified the presence of increased calmodulin, Src, and phosphorylated Src in the Fas-associated protein complex upon Fas activation. Trifluoperazine, a calmodulin antagonist, inhibited Fas-induced recruitment of calmodulin, Src, and phosphorylated Src. Consistently, trifluoperazine blocked Fas-promoted cell survival. A direct interaction of calmodulin and Src and their binding site were identified with recombinant proteins. These results support an essential role of calmodulin in mediating Fas-induced FADD-independent activation of Src-ERK signaling pathways, which promote survival signaling in pancreatic cancer cells. Understanding the molecular mechanisms responsible for the resistance of pancreatic cells to apoptosis induced by Fas-death receptor signaling may provide molecular insights into designing novel therapies to treat pancreatic tumors. Pancreatic cancer remains a devastating malignancy with a poor prognosis and is largely resistant to current therapies. To understand the resistance of pancreatic tumors to Fas death receptor-induced apoptosis, we investigated the molecular mechanisms of Fas-activated survival signaling in pancreatic cancer cells. We found that knockdown of the Fas-associated protein with death domain (FADD), the adaptor that mediates downstream signaling upon Fas activation, rendered Fas-sensitive MiaPaCa-2 and BxPC-3 pancreatic cells resistant to Fas-induced apoptosis. By contrast, Fas activation promoted the survival of the FADD knockdown MiaPaCa-2 and BxPC-3 cells in a concentration-dependent manner. The pharmacological inhibitor of ERK, PD98059, abrogated Fas-promoted cell survival in FADD knockdown MiaPaCa-2 and BxPC-3 cells. Furthermore, increased phosphorylation of Src was demonstrated to mediate Fas-induced ERK activation and cell survival. Immunoprecipitation of Fas in the FADD knockdown cells identified the presence of increased calmodulin, Src, and phosphorylated Src in the Fas-associated protein complex upon Fas activation. Trifluoperazine, a calmodulin antagonist, inhibited Fas-induced recruitment of calmodulin, Src, and phosphorylated Src. Consistently, trifluoperazine blocked Fas-promoted cell survival. A direct interaction of calmodulin and Src and their binding site were identified with recombinant proteins. These results support an essential role of calmodulin in mediating Fas-induced FADD-independent activation of Src-ERK signaling pathways, which promote survival signaling in pancreatic cancer cells. Understanding the molecular mechanisms responsible for the resistance of pancreatic cells to apoptosis induced by Fas-death receptor signaling may provide molecular insights into designing novel therapies to treat pancreatic tumors." @default.
• W1970782264 created "2016-06-24" @default.
• W1970782264 creator A5008301926 @default.
• W1970782264 creator A5009099023 @default.
• W1970782264 creator A5010289974 @default.
• W1970782264 creator A5028125012 @default.
• W1970782264 creator A5038178209 @default.
• W1970782264 creator A5038598323 @default.
• W1970782264 creator A5044301848 @default.
• W1970782264 creator A5065673727 @default.
• W1970782264 creator A5072740925 @default.
• W1970782264 date "2011-07-01" @default.
• W1970782264 modified "2023-10-15" @default.
• W1970782264 title "Calmodulin Mediates Fas-induced FADD-independent Survival Signaling in Pancreatic Cancer Cells via Activation of Src-Extracellular Signal-regulated Kinase (ERK)" @default.
• W1970782264 cites W1480949286 @default.
• W1970782264 cites W1506302012 @default.
• W1970782264 cites W1520674641 @default.
• W1970782264 cites W1523783037 @default.
• W1970782264 cites W1560096663 @default.
• W1970782264 cites W1616910822 @default.
• W1970782264 cites W1642763135 @default.
• W1970782264 cites W1836073275 @default.
• W1970782264 cites W1925295143 @default.
• W1970782264 cites W1941334139 @default.
• W1970782264 cites W1970213932 @default.
• W1970782264 cites W1970882491 @default.
• W1970782264 cites W1970962289 @default.
• W1970782264 cites W1975291295 @default.
• W1970782264 cites W1980542725 @default.
• W1970782264 cites W1981404696 @default.
• W1970782264 cites W1986331996 @default.
• W1970782264 cites W1995715853 @default.
• W1970782264 cites W1999202100 @default.
• W1970782264 cites W2002503549 @default.
• W1970782264 cites W2006275452 @default.
• W1970782264 cites W2009626612 @default.
• W1970782264 cites W2016345107 @default.
• W1970782264 cites W2022145079 @default.
• W1970782264 cites W2022589671 @default.
• W1970782264 cites W2032560191 @default.
• W1970782264 cites W2049174797 @default.
• W1970782264 cites W2058855556 @default.
• W1970782264 cites W2060365508 @default.
• W1970782264 cites W2063036476 @default.
• W1970782264 cites W2071622146 @default.
• W1970782264 cites W2073338516 @default.
• W1970782264 cites W2076355885 @default.
• W1970782264 cites W2081236313 @default.
• W1970782264 cites W2084765883 @default.
• W1970782264 cites W2086243042 @default.
• W1970782264 cites W2086436667 @default.
• W1970782264 cites W2101179323 @default.
• W1970782264 cites W2104018418 @default.
• W1970782264 cites W2109317345 @default.
• W1970782264 cites W2113026440 @default.
• W1970782264 cites W2119928565 @default.
• W1970782264 cites W2120385383 @default.
• W1970782264 cites W2127080680 @default.
• W1970782264 cites W2129115464 @default.
• W1970782264 cites W2132663758 @default.
• W1970782264 cites W2132954482 @default.
• W1970782264 cites W2135201591 @default.
• W1970782264 cites W2136103100 @default.
• W1970782264 cites W2139149736 @default.
• W1970782264 cites W2145611701 @default.
• W1970782264 cites W2157935840 @default.
• W1970782264 cites W2169932535 @default.
• W1970782264 cites W2170168836 @default.
• W1970782264 cites W2172196619 @default.
• W1970782264 cites W4211122150 @default.
• W1970782264 cites W4255760236 @default.
• W1970782264 doi "https://doi.org/10.1074/jbc.m110.202804" @default.
• W1970782264 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3137053" @default.
• W1970782264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21613217" @default.
• W1970782264 hasPublicationYear "2011" @default.
• W1970782264 type Work @default.
• W1970782264 sameAs 1970782264 @default.
• W1970782264 citedByCount "42" @default.
• W1970782264 countsByYear W19707822642012 @default.
• W1970782264 countsByYear W19707822642013 @default.
• W1970782264 countsByYear W19707822642014 @default.
• W1970782264 countsByYear W19707822642015 @default.
• W1970782264 countsByYear W19707822642016 @default.
• W1970782264 countsByYear W19707822642017 @default.
• W1970782264 countsByYear W19707822642018 @default.
• W1970782264 countsByYear W19707822642019 @default.
• W1970782264 countsByYear W19707822642020 @default.
• W1970782264 countsByYear W19707822642022 @default.
• W1970782264 countsByYear W19707822642023 @default.
• W1970782264 crossrefType "journal-article" @default.
• W1970782264 hasAuthorship W1970782264A5008301926 @default.
• W1970782264 hasAuthorship W1970782264A5009099023 @default.
• W1970782264 hasAuthorship W1970782264A5010289974 @default.
• W1970782264 hasAuthorship W1970782264A5028125012 @default.
• W1970782264 hasAuthorship W1970782264A5038178209 @default.
• W1970782264 hasAuthorship W1970782264A5038598323 @default.
• W1970782264 hasAuthorship W1970782264A5044301848 @default.
• W1970782264 hasAuthorship W1970782264A5065673727 @default.

• next